Nearly one in three people globally unknowingly carries Golden staph, or Staphylococcus aureus, in their nose or on their skin. While the bacterium is harmless to most, it can lead to serious ...
Recent FDA feedback supports the proposed primary efficacy endpoint for SER-155, which enhances the company's prospects for advancing its clinical studies. Breakthrough Therapy designation from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback